Table 1.

Assayed Chemokines in Intestinal, Hepatic, and Pulmonary Tissues Following Cellular Therapy for Intestinal I/R

		12 hour Reperfusion			24 hour Reperfusion
		PBS	hASC	Keratinocytes	PBS	hASC	Keratinocytes
Intestine	VEGF	49.31	48.5	40.1	47.5	52.7	52.1
		34.2-65.8	20.6-66.3	0-49.6	29.2-71.2	27.8-80.8	0-106.6
	GCSF	291.9	300.8	396.7	1609	201.4 *	487.2
		32.3-958.3	77.4-1477	97.3-1700	1379-3533	178.7-410.2	210.3-2557
	MIG	523.4	316.9	453.8	399.8	534.5	604.4
		314.6-707.5	245.2-389	373.5-487.8	345.6	568.1	396.0-738.0
	IL6	961.1	210.5	716.7	235.7	91.56	164.9
		52.3-2860	122.6-1004	70.0-1413	136.5-582.2	51.03-144.8	81.2-1169
	IL1β	49.3	48.5	40.4	47.5	52.7	52.1
		34.2-65.8	20.6-66.3	0-49.6	29.2-71.2	27.8-80.8	0-106.6
Liver	VEGF	22.8	21	19.5	27.7	36.1	22.1
		19.4-27.6	18.0-30.0	15-24.5	17.6-39.3	19.7-42.8	12.1-27.8
	GCSF	17.1	42.1	239	197	25.2 *#	157.8
		11.8-158.5	8.2-216.3	29.0-296.0	112.2-343.1	23.4-46.1	79.6-370.1
	MIG	183.7	133.1	571.8	142	163.5	351.8
		108.2-281.6	113.7-228.9	326.6-654.7	118.0-205.6	93.2-183.8	106.0-396.7
	IL6	85.2	92.1	121.4	122.2	76.1	111.5
		67.1-195.6	78.2-155.5	113.6-137.7	69.1-131.5	69.6-95.6	71.2-166.1
	IL1β	30.6	42.8 *#	21.7	43.2	46.2	30
		23.0-33.1	30.8-56.5	18.1-31.6	26.7-64.2	20.6-60.5	21.1-30.1
Lung	VEGF	77.8	70.1	49.4	23	128.1 *	75.1
		46.5-91.5	35.1-75.3	28.0-83.8	20.7-73.1	81.0-145.7	37.8-83.5
	GCSF	104.3	94.1	785.2	958	83.1 *#	542.5
		43.3-1639	34.2-906.9	518.1-1339	512.7-1782	50.1-167.8	430.8-2154
	MIG	66.5	69.7 #	266.7	89.7	59.9 #	128.6
		59.7-83.4	40.2-124.3	149.4-277.6	63.8-132.7	49.3-82.0	97.1-138.1
	IL6	69.3	26.5	361.3	68.8	0 *#	153.6
		14.5-3661.0	14.02-210.7	78.1-1105	18.4-103.7	0-11.6	84.2-1382.0
	IL1β	56.8	36.9	59.2	40.6	33.1 *#	52.6
		38.6-100.9	22.6-71.1	54.3-63.2	33.7-58.6	29.6-56.2	39.9-67.8

^*p<0.05 versus PBS

^#p<0.05 versus keratinocytes